Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-10
DOI: 10.2147/dddt.s601777 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Yang Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Rituximab, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
- Department of Nephrology, Yingtan 184 Hospital, Yingtan, People's Republic of China.
- Department of Nephrology, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, People's Republic of China.
- Department of Nephrology, the First Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China.
- Department of Health Management Center, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.
Zitieren
APA
Yang, Y., Xie, X., Yuan, F., Zeng, F., Wang, Y., Zhang, R., Yan, W., Luo, K., Ren, D., & Xu, G. (2026). Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s601777
Vancouver
Yang Y, Xie X, Yuan F, Zeng F, Wang Y, Zhang R, et al. Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s601777
BibTeX
@article{Yang2026,
author = {Yang, Yang and Xie, Xiaojie and Yuan, Fan and Zeng, Fang and Wang, Yu and Zhang, Ran and Yan, Wenjun and Luo, Kaiping and Ren, Daijin and Xu, Gaosi},
title = {Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/dddt.s601777}
}
EUVIMED